SENORES PHARMACEUTICALS L Cash Flow Quality Index
SENORES PHARMACEUTICALS L cash flow quality index. SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow Quality Index of 0.46x as of September 2025. Operating cash flow of Rs242.20 Million is below net income of Rs521.10 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is SENORES PHARMACEUTICALS L to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of SENORES PHARMACEUTICALS L (2022–2026)
Cash flow quality index of SENORES PHARMACEUTICALS L from 2022 to 2026. Historical Cash Flow Quality Index for SENORES PHARMACEUTICALS L across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore SENORES cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
SENORES PHARMACEUTICALS L Cash Flow Quality Index by Year (2022–2026)
SENORES PHARMACEUTICALS L cash flow quality index by year from 2022 to 2026. Year-by-year earnings quality comparison for SENORES PHARMACEUTICALS L. For the full cash flow conversion analysis, see cash efficiency ratio of SENORES PHARMACEUTICALS L.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 0.39x | Rs620.50 Million | Rs1.59 Billion | ▲ +159.9% |
| 2025 | -0.65x | Rs-459.20 Million | Rs705.70 Million | ▲ +20.4% |
| 2024 | -0.82x | Rs-257.00 Million | Rs314.55 Million | ▼ -538.6% |
| 2023 | -0.13x | Rs-10.79 Million | Rs84.33 Million | ▲ +98.8% |
| 2022 | -10.54x | Rs-104.47 Million | Rs9.91 Million | — |